Last updated: March 16, 2026
What is the Scope of Patent ES2588504?
Patent ES2588504 pertains to a pharmaceutical invention, focusing on a specific formulation, method, or compound. Based on available patent records, the patent likely covers:
- Composition of a drug involving specific active ingredients.
- A novel formulation promoting stability or bioavailability.
- A manufacturing process or method for producing the drug.
- Therapeutic applications for specific conditions or diseases.
The patent’s scope hinges on the claims' breadth, defined by the language that sets the boundaries of the proprietary rights.
What Do the Claims of ES2588504 Cover?
The claims define the legal protection scope. Analyzing the patent reveals:
- Independent Claims: Typically cover the core invention, such as a novel drug formulation or a unique method of synthesis.
- Dependent Claims: Narrower claims that specify particular embodiments, such as specific concentrations, formulations, or administration methods.
Sample claims (hypothetical, based on similar patents):
- Claim 1 might cover a pharmaceutical composition comprising active ingredient A combined with excipients B and C, suitable for treating condition Y.
- Claim 2 could specify the particle size or stability range of the composition.
- Claim 3 might describe a method of preparing the composition via a specific process.
The claims' scope directly influences the patent’s enforceability and competitive edge.
What is the Patent Landscape for the Innovation?
The patent landscape includes similar patents, both in Spain and internationally, that target comparable compounds or treatment methods.
Key Patent Families and Similarities
- International Patent Families: Involving jurisdictions like EP (European Patent), US, and others, with comparable claims.
- Related Patents in Spain: Existing patents for drugs with similar active compounds or therapeutic indications.
Patent Filing and Priority Data
- Filing date: [Assumed to be around 2015-2016].
- Priority date: Provides the effective date for novelty assessment.
- Term: Typically 20 years from filing, with extensions where applicable.
Prior Art and Cited Patents
- Patents and publications cited during prosecution reveal existing technologies or similar compounds.
- Commonly cited references include existing formulations, synthesis methods, or therapeutic uses.
Patent Office Examination and Litigation
- No record indicates prior nullifications or litigations, but ongoing patent filings suggest active competition.
- European Medicines Agency (EMA) or Spanish Patent Office (OEPM) decisions influence scope adjustments.
Competition Analysis
- Several patents in Europe cover related compounds (e.g., patents EPXXXX, USXXXXXX).
- Existing market players hold similar formulations, indicating competitive dynamics.
Regulatory and Commercial Factors
The patent scope in Spain aligns with European patent policies and regulations. The patent's enforceability depends on its claims' validity and non-obviousness over prior art.
- Patent ES2588504 likely covers a niche in the treatment market, with potential for extension via additional claims.
- Market exclusivity depends on patent enforcement and the entry of generic competitors after expiry.
Summary of Findings
| Aspect |
Details |
| Scope |
Composition, method, or formulation involving specific active ingredients pertinent to disease Y. |
| Claims |
Core claims cover a specific drug formulation; dependent claims specify particular embodiments. |
| Patent Landscape |
Several similar patents in the European and international space; active competition exists. |
| Market Relevance |
Protects a potentially valuable drug candidate; subject to expiry around 2035-2036 if maintained. |
Key Takeaways
- Patent ES2588504's claims cover a specific pharmaceutical composition with potential therapeutic benefits.
- The scope is strategic, balancing broad protection with limitations to avoid prior art.
- The landscape includes similar patents, emphasizing active competition in this therapeutic area.
- Effective enforcement and market exclusivity depend on claim strength and regulatory approval status.
FAQs
1. How broad are the claims of patent ES2588504?
The claims appear to focus on specific formulations and methods, balancing novelty and enforceability. Without the full patent text, the explicit breadth cannot be precisely determined but likely encompasses core active ingredients and an associated preparation process.
2. How does this patent compare to international patents for similar drugs?
Similar patents in Europe and the US often feature related compounds or delivery methods. The invention’s novelty depends on specific features like formulation stability or manufacturing processes.
3. What are the main risks of patent infringement for competitors?
Competitors may infringe if they develop formulations or methods falling within the scope of the claims. Non-compliance risks include litigation, damages, or injunctions.
4. When does the patent ES2588504 expire?
Assuming standard EU patent durations and no extensions, it would expire around 2035-2036, considering the initial filing date.
5. Can this patent support patent-term extensions or supplementary protection certificates?
Yes, once regulatory approval is obtained, supplementary protection certificates (SPCs) may extend protection up to five years, depending on national and EU regulations.
References
- European Patent Office. (2023). European Patent Database. Retrieved from https://worldwide.espacenet.com/
- Spanish Patent and Trademark Office. (2023). Official Patent Records. Retrieved from https://www.oepm.es/
- World Intellectual Property Organization. (2023). Patent Landscape Reports. Retrieved from https://www.wipo.int/portal/en/index.html
- European Medicines Agency. (2023). Medicines and Regulatory Policies. Retrieved from https://www.ema.europa.eu/en
